Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects.

Abstract excerpt

Cystic fibrosis (CF) is a genetic disorder that causes multiorgan morbidity and premature death, most commonly from pulmonary dysfunction. Mutations in the CF transmembrane conductance regulator (CFTR) gene, of which almost 2000 have been described, result in a dysfunctional CFTR protein. This protein is an adenosine triphosphate binding anion channel, present primarily at the surface of epithelial cells. Loss of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Aminophenols
• Share to Aminopyridines
• Share to Benzodioxoles